Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Purpose: To study the etiology and the epigenetic pathways leading to and regulating chronic
itch. Similarly, to examine the mechanisms underlying skin changes, including epigenetic
alterations while also testing the efficacy of opioid antagonists in atopic dermatitis. In
this study, the investigators aim to examine chronic sensory disorder mechanisms related to
chronic itch.